Wednesday, July 8, 2026

pharma · Recurrent Pericarditis · Sjögren’s Disease · KNSA

Kiniksa Pharmaceuticals International

News and analysis for Kiniksa Pharmaceuticals International on NovaPharmaNews — regulatory, clinical, and market coverage.

100 Hayden Ave, Lexington, Massachusetts 02421, US HQ
2015 Founded
381 Employees
Public company Type
KNSA · NYSE Ticker
Company details
Status
Public
HQ
100 Hayden Ave, Lexington, Massachusetts 02421, US
Founded
2015
Employees
381
Programs
14
Drugs
7
Patents
9
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Kiniksa Pharmaceuticals International — regulatory, clinical, and market coverage.

News and analysis for Kiniksa Pharmaceuticals International on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Kiniksa Pharmaceuticals International yet.

Back to company overview →